The DOI matches its Crossref record.
Low Levels of Sex Hormone-binding Globulin and Testosterone Predict the Development of Non-Insulin-dependent Diabetes Mellitus in Men
Abstract
Few prospective data are available regarding the association of sex hormone-binding globulin (SHBG), testosterone, and the risk of developing diabetes. Stored fasting serum samples from participants enrolled in the Multiple Risk Factor Intervention Trial (MRFIT) at 22 centers throughout the United States from December 1973 through February 1976 were used to perform a nested case- control study. For 176 initially nondiabetic men who had developed diabetes during 5 years of follow-up, two controls were selected, one matched only for randomization date, treatment group, and clinic ("loose controls") and the other matched additionally for fasting glucose and body mass index ("tight controls"). When cases were compared with lose controls, higher levels of fasting insulin and lower levels of total and free testosterone and SHBG were significantly associated with increased development of diabetes. However, when cases were compared with tightly matched controls, these associations weakened considerably. Low SHBG and testosterone may constitute part of the prediabetic state in men along with previously reported variables, such as higher glucose and insulin levels and obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low testosterone levels have also been found to predict insulin resistance and the future development of type 2 diabetes (3-5).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [5]
Citations
Cited by
Sorted by citations
Items 101–200 of 319
Coviello, A. D., Sam, S., Legro, R. S., & Dunaif, A. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1333 · Cited by 77
“Low T levels in the general male population have been associated with central adiposity, higher insulin levels, MetS, and type 2 diabetes (17, 18, 28, 29).”
BackgroundTestosterone and Erectile Dysfunction
Yassin, A. A., & Saad, F. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.004630 · Cited by 73
Therkelsen, K. E., Abraham, T. M., Pedley, A., Massaro, J. M., Sutherland, P. A., Hoffmann, U., & Fox, C. S. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002640 · Cited by 71
“Low sex hormone–binding globulin has been prospectively associated with increased odds of incident diabetes.(33,35,36) Although the mechanism and causality of this association has not been fully characterized, it is possible that elevated prolactin may influence diabetes risk by inhibiting production of sex hormone–bi…”
Svartberg, J. B., Jenssen, T. G., Sundsfjord, J., & Jorde, R. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70086-1 · Cited by 70
“In addition, low levels of testosterone have been reported to predict insulin resistance and incident type 2 diabetes in older men [7, 8].”
Liu, P. Y., Wishart, S. M., Celermajer, D., Jimenez, M., di Pierro, I., Conway, A., & Handelsman, D. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480055 · Cited by 69
Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey
Hall, S. A., Page, S. T., Travison, T. G., Montgomery, R. B., Link, C. L., & McKinlay, J. B. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0306 · Cited by 69
“Consistent with this explanation, low levels of SHBG have been associated with the development of type 2 diabetes and the metabolic syndrome (31-35).”
Metabolic syndrome and infertility in men
Morrison, C. D., & Brannigan, R. E. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.10.006 · Cited by 70
Salehzadeh, F., Rune, A., Osler, M., & Al-Khalili, L. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0497 · Cited by 66
Body composition, metabolic syndrome and testosterone in ageing men
Allan, C. A., Strauss, B. J. G., & McLachlan, R. I. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901552 · Cited by 67
Genetic variants of sex hormone-binding globulin and their biological consequences
Xita, N. V., & Tsatsoulis, A. A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.025 · Cited by 63
Liu, S., & Sun, Q. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12517 · Cited by 64
Epidemiology: testosterone and the metabolic syndrome
Svartberg, J. B. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901499 · Cited by 61
Lin, C., Chiang, J.-H., Li, C.-I., Liu, C. S., Lin, W. Y., Hsieh, T.-F., & Li, T.-C. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-381 · Cited by 60
“Previous studies have also indicated that diabetic men have lower testosterone levels [45], which suggest a decreased risk in prostate cancer.”
Testosterone a key factor in gender related metabolic syndrome
Bianchi, V. E., & Locatelli, V. (2018) · Obesity Reviews · doi:10.1111/obr.12633 · Cited by 65
Fenske, B., Kische, H., Groß, S., Wallaschofski, H., Völzke, H., Dörr, M., Nauck, M. A., Keevil, B. G., Brabant, G. E., & Haring, R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2546 · Cited by 59
“Consequently, low SHBG was described as independent predictor of incident T2DM (10), reflecting a prediabetic state along with obesity, higher glucose and insulin levels (11, 14, 15).”
Obesity, Male Reproductive Function and Bariatric Surgery
Vincenzo, A. D., Busetto, L., Vettor, R., & Rossato, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00769 · Cited by 59
Inaba, M., Otani, Y., Nishimura, K., Takaha, N., Okuyama, Ä., Koga, M., Azuma, J., Kawase, I., & Kasayama, S. (2004) · Metabolism · doi:10.1016/j.metabol.2004.07.010 · Cited by 58
Kapoor, D., Channer, K. S., & Jones, T. H. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.022 · Cited by 58
Fritz, K. S., McKean, A. J. S., Nelson, J. C., & Wilcox, R. B. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.094870 · Cited by 58
Gyawali, P., Martin, S., Heilbronn, L. K., Vincent, A. D., Taylor, A. W., Adams, R., O’Loughlin, P. D., & Wittert, G. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1163-6 · Cited by 58
“The discrepancies between the majority of findings from other longitudinal studies, including our own, is likely related to differences in the definition [9, 10, 14, 15, 23–25], and/or low number of cases [10, 24], of incident diabetes; the populations studied [8, 14, 17]; lack of standardized blood sampling time [11,…”
Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
Song, M. J., & Choi, J. Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1053709 · Cited by 65
“Low testosterone and SHBG in men are independent predictors of metabolic syndrome (68).”
BackgroundPromising role of medicinal plants in the regulation and management of male erectile dysfunction
Masuku, N. P., Unuofin, J. O., & Lebelo, S. L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110555 · Cited by 58
Gascón, F., Valle, M., Martos, R., Rodríguez, F. J. R., Ríos, R., Montilla, P., & Cañete, R. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430085 · Cited by 55
Androgen Deficiency as a Predictor of Metabolic Syndrome in Aging Men
Kapoor, D., & Jones, T. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825050-00001 · Cited by 52
Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.
Cattabiani, C., Basaria, S. S., Ceda, G. P., Luci, M., Vignali, A., Lauretani, F., Valenti, G., Volpi, R., & Maggio, M. G. (2012) · PubMed · doi:10.3275/8061 · Cited by 52
Estrogenic side effects of androgen deprivation therapy.
Guise, T. A., Oefelein, M. G., Eastham, J. A., Cookson, M. S., Higano, C. S., & Smith, M. R. (2007) · Europe PMC (PubMed Central) · Cited by 51
Adverse health effects of testosterone deficiency (TD) in men
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.010 · Cited by 51
Endocrine complications of androgen-deprivation therapy in men with prostate cancer.
Harle, L., Maggio, M., Shahani, S., Braga‐Basaria, M., & Basaria, S. S. (2006) · PubMed · Cited by 52
Resistance training increases SHBG in overweight/obese, young men
Roberts, C. K., Croymans, D. M., Aziz, N., Butch, A. W., & Lee, C. C. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.004 · Cited by 50
“[28] Haffner SM, Shaten J, Stern MP, et al.”
Schipf, S., Haring, R., Friedrich, N., Nauck, M. A., Lau, K., Alte, D., Stang, A., Völzke, H., & Wallaschofski, H. (2010) · The Aging Male · doi:10.3109/13685538.2010.524955 · Cited by 52
Phillips, G. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2011 · Cited by 51
Mechanisms of obesity-induced male infertility
Phillips, K. P., & Tanphaichitr, N. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.65 · Cited by 51
RAS and sex differences in diabetic nephropathy
Clotet, S., Riera, M., Pascual, J., & Soler, M. J. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00292.2015 · Cited by 49
Diabetes and the risk of prostate cancer
Tavani, A., Gallus, S., Bosetti, C., Τζώνου, Α., Λάγιου, Π., Negri, E., Trichopoulos, D., & Vecchia, C. L. (2002) · European Journal of Cancer Prevention · doi:10.1097/00008469-200204000-00003 · Cited by 50
“Diabetes, mainly type II diabetes, has been related to changes in serum testosterone levels (Gann et al., 1996; Haffner et al., 1996; Defay et al., 1998), which may affect the process of prostatic carcinogenesis (Hsing, 1996).”
Andropause: invention, prevention, rejuvenation
Handelsman, D. J., & Liu, P. Y. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.01.002 · Cited by 49
Biochemical hypogonadism in men with type 2 diabetes in primary care practice
Hackett, G. I., Cole, N., Deshpande, A. A., Popple, M. D., Kennedy, D., & Wilkinson, P. R. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409342635 · Cited by 49
Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus
Kamenov, Z. A., Parapunova, R., & Georgieva, R. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.11.001 · Cited by 49
Traish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 50
Postload plasma glucose concentration and 27-year prostate cancer mortality (United States)
Gapstur, S. M., Gann, P. H., Colangelo, L. A., Barron-Simpson, R., Kopp, P. A., Dyer, A. R., & Liu, K. (2001) · Cancer Causes & Control · doi:10.1023/a:1011279907108 · Cited by 47
Onat, A., Hergenç, G., Karabulut, A., Albayrak, S., Can, G., & Kaya, Z. (2007) · Metabolism · doi:10.1016/j.metabol.2007.05.020 · Cited by 47
Bonnet, F., Balkau, B., Malécot, J.-M., Picard, P., Lange, C., Fumeron, F., Aubert, R., Raverot, V., Déchaud, H., Tichet, J., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0202 · Cited by 47
The aging male: testosterone deficiency and testosterone replacement. An up-date
Alexandersen, P., & Christiansen, C. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00242-9 · Cited by 45
Nandrolone decanoate inhibits gluconeogenesis and decreases fasting glucose in Wistar male rats
Frankenfeld, S. P., de Oliveira, L. P., Ignacio, D. L., Coelho, R. G., Nigro, M., Ferreira, A. C. F., de Carvalho, D. P., & Fortunato, R. S. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0259 · Cited by 44
Li, Z., Liu, N., Jiang, Y., Yang, J., Zheng, J., Sun, M., Li, Y., Sun, T., Wu, J. H., & Yu, J. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.10.013 · Cited by 45
Androgens, Obesity, and Sleep-Disordered Breathing in Men
Liu, P. Y., Caterson, I. D., Grunstein, R. R., & Handelsman, D. J. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.03.002 · Cited by 43
“Insulin resistance is associated with obesity, particularly abdominal obesity, and with low serum testosterone concentrations [64,65].”
BackgroundTestosterone-Associated Dietary Pattern Predicts Low Testosterone Levels and Hypogonadism
Hu, T.-Y., Chen, Y.-C., Lin, P., Shih, C., Bai, C., Yuan, K.-C., Lee, S.-Y., & Chang, J. (2018) · Nutrients · doi:10.3390/nu10111786 · Cited by 43
Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study
Soriguer, F., Rubio‐Martín, E., Fernández, D., Valdés, S., García‐Escobar, E., Martín‐Núñez, G. M., Esteva, I., Almaraz, M. C., & Rojo‐Martínez, G. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02559.x · Cited by 43
Testosterone and body functions
Köhn, F. M. (2006) · The Aging Male · doi:10.1080/13685530601060396 · Cited by 45
Huang, G., Pencina, K. M., Li, Z., Basaria, S., Bhasin, S., Travison, T. G., Storer, T. W., Harman, S. M., & Tsitouras, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02545 · Cited by 40
Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications
Kumar, M., Dutta, D., Anne, B., Shivaprasad, Sinha, A., Ray, S., & Chowdhury, S. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s50777 · Cited by 42
Ho, C.-H., Yu, H.-J., Wang, C.-Y., Jaw, F.-S., Hsieh, J.-T., Liao, W.-C., Pu, Y.-S., & Liu, S.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074173 · Cited by 40
Joyce, K. E., Biggs, M. L., Djoussé, L., Ix, J. H., Kizer, J. R., Siscovick, D. S., Shores, M. M., Matsumoto, A. M., & Mukamal, K. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2623 · Cited by 40
“Although we observed no interaction with age and race (data not shown), there was a borderline interaction with BMI 25 kg/m2 (P .04).”
InfluentialMetabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome
Hackett, G. I. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.12.004 · Cited by 39
Type 2 Diabetes and Testosterone Therapy
Hackett, G. I. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180027 · Cited by 39
Male Obesity Associated Gonadal Dysfunction and the Role of Bariatric Surgery
Sultan, S., Patel, A. G., El-Hassani, S., Whitelaw, B., Leca, B. M., Vincent, R. P., le Roux, C. W., Rubino, F., Aywlin, S. J. B., & Dimitriadis, G. K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00408 · Cited by 39
“Both showed results that are consistent with the wider literature, which is that low levels of testosterone and SHBG were strongly associated with the development of diabetes (20, 21).”
Hypogonadotrophic hypogonadism in type 2 diabetes
Dandona, P., Dhindsa, S., Chaudhuri, A., Bhatia, V., & Topiwala, S. (2008) · The Aging Male · doi:10.1080/13685530802317934 · Cited by 38
Metabolic and cardiovascular risk factors in Klinefelter syndrome
Spaziani, M., & Radicioni, A. F. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31792 · Cited by 38
Traish, A. M., Abdallah, B., & Yu, G. W. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.132 · Cited by 37
Sex steroids and glucose metabolism
Allan, C. A. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122589 · Cited by 38
Chunchai, T., Apaijai, N., Keawtep, P., Mantor, D., Arinno, A., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Acta Physiologica · doi:10.1111/apha.13229 · Cited by 34
Testosterone Replacement Therapy and Mortality in Older Men
Hackett, G. I. (2015) · Drug Safety · doi:10.1007/s40264-015-0348-y · Cited by 34
“Large long-term studies have shown that baseline levels of testosterone predict the later development of T2DM [39, 64].”
InfluentialSex Hormones, Insulin Resistance, and Diabetes Mellitus Among Men With or at Risk for HIV Infection
Monroe, A. K., Dobs, A. S., Xu, X., Palella, F. J., Kingsley, L., Witt, M. D., & Brown, T. T. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182278c09 · Cited by 34
Testosterone deficiency, insulin-resistant obesity and cognitive function
Pintana, H., Chattipakorn, N., & Chattipakorn, S. C. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9655-3 · Cited by 33
“In addition, recent clinical studies demonstrated that obese patients with reduced testosterone levels can easily develop the metabolic syndrome as well as T2DM (Asare-Anane et al. 2014; Fui et al. 2014; Haring et al. 2010).”
InfluentialAndrogen therapy and atherosclerotic cardiovascular disease
McGrath, K. C. Y. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.11 · Cited by 33
“…et al 2003), or an atherogenic lipid profi le (Tchernof et al 1997; Zmuda et al 1997), metabolic syndrome (Kupelian et al 2006), type 2 diabetes (Haffner et al 1996; Stellato et al 2000), systolic and diastolic hypertension (Svartberg et al 2004), visceral obesity (Khaw and Barrett-Connor…”
Chen, C., Smothers, J., Lange, A., Nestler, J. E., Strauss, J. F., & Wickham, E. P. (2010) · PubMed · Cited by 32
., K. M. S. (2005) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2005.1152.1156 · Cited by 32
Thiruppathi, M., Dhevika, S., Palaniappan, M., & Balasubramanian, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.06.009 · Cited by 32
Metabolic syndrome and hypogonadism – two peas in a pod
Ebrahimi, F., & Christ‐Crain, M. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14283 · Cited by 32
Guay, A. T., & Traish, A. M. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.02.004 · Cited by 32
“A relationship between low SHBG and T exists such that low T predicts higher glucose and insulin levels as well as increased obesity.(21,22) Low levels of T and SHBG were thought to play a role in the development of IR and subsequently T2DM, based on the findings of the longitudinal Massachusetts Male Aging Study.”
Metabolic syndrome and semen quality in adult population
Chen, Y., Kao, T., Peng, T., Yang, H., Wu, C., & Chen, W. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12995 · Cited by 34
Phillips, G. B., Pinkernell, B. H., & Jing, T.-Y. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.008 · Cited by 31
Glycemic Status and Risk of Prostate Cancer
Darbinian, J. A., Ferrara, A. M., Eeden, S. K. V. D., Quesenberry, C. P., FIREMAN, B. H., & Habel, L. A. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2610 · Cited by 29
Yeşilova, Z., Öktenli, Ç., Sanisoğlu, S. Y., Muşabak, U., Çakır, E., Özata, M., & Dağalp, K. (2005) · Endocrine · doi:10.1385/endo:27:1:011 · Cited by 29
Lanfranco, F., Baldi, M., Cassoni, P., Bosco, M., Ghé, C., & Muccioli, G. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)77013-3 · Cited by 29
Insulin resistance and advancing age: What role for dehydroepiandrosterone sulfate?
Paolisso, G., Ammendola, S., Rotondi, M., Gambardella, A., Rizzo, M. R., Mazziotti, G., Tagliamonte, M. R., Carella, C., & Varricchio, M. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90231-6 · Cited by 27
An update on the role of testosterone replacement therapy in the management of hypogonadism
Hackett, G. I. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215617648 · Cited by 26
Duarte, R. V. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/9 · Cited by 24
Pintana, H., Pratchayasakul, W., Sa‐nguanmoo, P., Pongkan, W., Tawinvisan, R., Chattipakorn, N., & Chattipakorn, S. C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.015 · Cited by 22
49,XXXXY Syndrome with Diabetes Mellitus
Kim, H. J., Kim, D., Shin, J. M., et al. (2005) · Hormone Research in Paediatrics · doi:10.1159/000090327 · Cited by 22
Contreras, P. H., Serrano, F. G., Salgado, A. M., & Pilar Vigil, P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00190 · Cited by 22
Correlation of sex hormone and androgen receptor with diabetes mellitus in elderly men
Cao, J., Li, J., Hao, W., Li, X., Wang, H., Liu, L., Zhu, B., & Guo, Z. (2011) · The Aging Male · doi:10.3109/13685538.2011.575479 · Cited by 21
Male-specific consequences of obesity — functional hypogonadism and fertility disorders
Rabijewski, M. (2023) · Endokrynologia Polska · doi:10.5603/ep.95626 · Cited by 24
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
Braunstein, L. Z., Chen, M., Loffredo, M. J., Kantoff, P. W., & D'Amico, A. V. (2014) · Prostate Cancer · doi:10.1155/2014/230812 · Cited by 22
Mattack, N. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/11049.5381 · Cited by 21
Beyond reproduction: unraveling the impact of sex hormones on cardiometabolic health
Xega, V., & Liu, J. (2024) · Medical Review · doi:10.1515/mr-2024-0012 · Cited by 33
Testosterone, Diabetes Risk, and Diabetes Prevention in Men
Yeap, B. B., & Wittert, G. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.004 · Cited by 19
Insulin gene polymorphism and premature male pattern baldness in the general population.
Ellis, J. A., Stebbing, M., & Harrap, S. B. (1999) · Clinical science · doi:10.1042/cs0960659 · Cited by 10
Testosterone Deficiency, Cardiac Health, and Older Men
Hackett, G. I., Kirby, M. G., & Sinclair, A. J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/143763 · Cited by 17
Liu, T., Wang, Y., Qian, B., & Li, P. (2024) · BioMed Research International · doi:10.1155/2024/6640796 · Cited by 18
Xia, J.-W., Tan, S., Zhang, X., Jun, T., Sun, X., & Ling, W. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12291 · Cited by 17
Theodoraki, A., & Bouloux, P.-M. G. (2009) · Menopause international · doi:10.1258/mi.2009.009025 · Cited by 17
Sepu, N., Adeleye, J. O., & Kuti, M. A. (2021) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.11.014 · Cited by 16
Testosterone Deficiency in Older Men: A Problem Worth Treating
Martin, C. M. (2012) · The Consultant Pharmacist · doi:10.4140/tcp.n.2012.152 · Cited by 16
Clinicopathologic assessment of hypogonadism in men with type 2 diabetes mellitus
Ugwu, T. E., Ikem, R. T., Kolawole, B. A., & Ezeani, I. U. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.190554 · Cited by 16
“Similar findings have been reported elsewhere.[8] In contrast, Kapoor et al.”
ResultThe Significance of Low Testosterone Levels in Obese Men
Pelusi, C., & Pasquali, R. (2012) · Current Obesity Reports · doi:10.1007/s13679-012-0029-4 · Cited by 16
Androgen therapy and atherosclerotic cardiovascular disease
Heather, A. K. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1255 · Cited by 16
The prevalence of Hypogonadism among diabetic and non-diabetic men in Jordan
Hayek, A. A., Khawaja, N. M., Khader, Y. S., Jafal, S., & Ajlouni, K. M. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.11.004 · Cited by 15
Vargas, A., Machado, R. D., Filho, D. I., Paiva, C. E., dos Reis, R. B., Tobias‐Machado, M., & Faria, E. F. (2016) · World Journal of Urology · doi:10.1007/s00345-016-1831-5 · Cited by 13
Miyauchi, S., Miyake, T., Miyazaki, M., Eguchi, T., Niiya, T., Yamamoto, S., Senba, H., Furukawa, S., Matsuura, B., & Hiasa, Y. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0225 · Cited by 15
Krysiak, R. G., Gilowski, W., & Okopień, B. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.06.003 · Cited by 15
Metadata
- Authors
- Haffner, S. M., Shaten, J., Stem, M. P., Smith, G. D., Kuller, L., & MRFIT Research Group
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- University of Minnesota (US)
- University of Glasgow (GB)
- University of Pittsburgh (US)
- Corresponding author
- Shaten, J.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-05-01
- Volume
- 143
- Issue
- 9
- Pages
- 889-897
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2132837172
- Cited by
- 320
- References
- 0
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 7 · 2023: 5 · 2022: 7 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 13 · 2017: 13 · 2016: 12 · 2015: 14 · 2014: 15 · 2013: 17 · 2012: 14
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r37hl036820-10)
- National Heart, Lung, and Blood Institute (R37HL36820, R01HL024799, HL43232, R01HL043232, R01HL24799)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- sex hormone-binding globulin, testosterone, type 2 diabetes, type 2 diabetes risk, prediabetes, fasting insulin, free testosterone, men, Multiple Risk Factor Intervention Trial, obesity, fasting blood glucose
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Fasting, Humans, Insulin, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Risk Factors, Sex Factors, Sex Hormone-Binding Globulin, Testosterone, Body Mass Index, Case-Control Studies, Matched-Pair Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
